Columbus Circle Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Columbus Circle Investors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$17.4M	Sell	29,885 -11,022	-27%	-$6.28M	0.76%	46
2020 Q3	$21.1M	Sell	40,907 -614	-1%	-$311K	0.92%	34
2020 Q2	$18.7M	Buy	41,521 +10,439	+34%	+$4.61M	0.75%	50
2020 Q1	$10.9M	Sell	31,082 -7,450	-19%	-$2.74M	0.6%	66
2019 Q4	$14.3M	Buy	38,532 +11,002	+40%	+$3.88M	0.61%	57
2019 Q3	$9.16M	Buy	+27,530	New	+$8.98M	0.34%	99
2019 Q1	–	Sell	-86,217	Closed	-$20M	–	149
2018 Q4	$20M	Sell	86,217 -42,966	-33%	-$11.5M	0.57%	74
2018 Q3	$40.4M	Buy	129,183 +45,344	+54%	+$14.1M	0.81%	40
2018 Q2	$24.2M	Buy	+83,839	New	+$23.1M	0.5%	83

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Columbus Circle Investors's BIO Position: Q4 2020 in Review

Columbus Circle Investors reduced its Bio-Rad Laboratories Class A (BIO) stake by 27% in Q4 2020, selling an estimated $6.28M and leaving 29,885 shares worth $17.4M. The position accounts for 0.76% of the portfolio, ranked #46.

Columbus Circle Investors first reported a position in BIO in Q2 2018 and has held it in 9 quarters since. The position peaked at $40.4M in Q3 2018. 491 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

Columbus Circle Investors held 29,885 shares of Bio-Rad Laboratories Class A worth $17.4M as of Q4 2020.
Columbus Circle Investors sold 11,022 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $6.28M.
Bio-Rad Laboratories Class A made up 0.76% of Columbus Circle Investors's portfolio in Q4 2020, its #46 holding.
Columbus Circle Investors first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and has held it in 9 quarters since.
Columbus Circle Investors's Bio-Rad Laboratories Class A position peaked at $40.4M in Q3 2018.
491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.